Incannex Healthcare IXHL
NASDAQ IXHL
$3.31 +0.16 (+5.08%)
At close: Sep 29, 2026 · 4:00 PM EDT

Incannex Healthcare (IXHL) Receivables (2020 - 2023)

Updated

Incannex Healthcare (IXHL) recorded Receivables of $287,478 in fiscal Q4 2023 (quarter ended Jun 30, 2023), down 2.5% from $294,717 a year earlier.

Analysis

Incannex Healthcare (IXHL) Receivables (2020 - 2023) Analysis & Trends

Starting with fiscal Q4 2020, Incannex Healthcare's Receivables history includes 5 quarters.

  • Annual Receivables has a three-year compound annual growth rate of -11.4% (FY2020 to FY2023).
  • Across earlier fiscal years, Receivables came in at $294,717 in FY2022 (+32.4%), $222,535 in FY2021 (-46.2%) and $413,268 in FY2020.
  • The fiscal Q4 2023 figure is the lowest quarterly Receivables since fiscal Q4 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 19.05 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 13.82 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.56 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 9.64 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 15.68 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 10.23 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 5.06 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 12.49 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.13 Bn
10 Incannex Healthcare 39.52 Mn 39.52 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 287,478.00
Dec 31, 2022 449,843.00
Jun 30, 2022 294,717.00
Jun 30, 2021 222,535.00
Jun 30, 2020 413,268.00
API Access

Incannex Healthcare Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=IXHL&period=max&api_key=YOUR_API_KEY